As these paradigms use chronic administration of estrogens, the classical estrogen receptor (ER) isoforms, ERα and ERβ, are thought to slowly regulate anxiety via transcription (Nilsson et al. 2001). However, administration of 10 μg/kg 17β estradiol exerted anxiolytic effects in the elevated T-maze within 30 min in OVX rats (Kalandakanond-Thongsong et al. 2012),

whereas administration of 25 μg/kg 17β estradiol to female mice was an anxiogenic in the EPM and open field (Kastenberger et al. 2012) tasks within 2 h of a single injection. These studies implicate a rapid, possibly Inhibitors,research,lifescience,medical nongenomic, mode of signaling by 17β estradiol that contributes to state anxiety. One candidate for nongenomic signaling by 17β estradiol is the GPR30, a former orphan G-protein coupled receptor that binds 17β estradiol with a Kd value of 6 nmol/L (Thomas et al. 2005). The expression of GPR30 Inhibitors,research,lifescience,medical in the hippocampus and the central amygdala (Hazell et al. 2009) suggests that this receptor contributes to some of 17β estradiol’s Inhibitors,research,lifescience,medical effect on the limbic system. In OVX rats, chronic administration of the

specific GPR30 agonist, G-1 at 5 μg/day improved memory on a delayed matching to place (DMP) task that requires hippocampally encoded spatial memory (Hammond et al. 2009). In OVX acutely stressed mice, GPR30 expression increased in the basolateral amygdala and G-1 regulated the NMDA receptor system to increase inhibitory synaptic transmission (Tian et al. 2013), thus decreasing anxiety. Contrary

to this anxiolytic effect of GPR30 activation, Kastenberger et al. (2012) showed that 1 mg/kg body weight of G-1 given 2 h before testing to OVX female Inhibitors,research,lifescience,medical mice increased anxiety in the EPM and OFT, but not in the LDT. Hence, similar to the studies that show both anxiolytic and anxiogenic effects of 17β estradiol, GPR30 Wortmannin purchase activation by the use of a selective agonist also leads to differing effects on state anxiety that are dependent on dose and timing. As recent studies suggest that enhanced performance on spatial tasks is correlated with lower anxiety Inhibitors,research,lifescience,medical (Kheirbek et al. 2013; Olsen et al. 2013), we hypothesized that the enhancement seen in the DMP task ADP ribosylation factor in OVX rats with chronic administration of G-1 (Hammond et al. 2009) could be due to an anxiolytic effect of GPR30 activation. Hence, adult ovariectomized mice chronically administered, via silastic implants, EB, G-1, or vehicle were tested on the EPM task and the open field test. Our second hypothesis was that the anxiolytic effect exerted by G-1 would correlate with increased extracellular-regulated kinase (ERK) activation as well as the subsequent phosphorylation of an ERK target – the serine 118 of the ERα itself (Kato et al. 1995) – in the hippocampus. This is because GPR30 activation increased ERK activation in a breast cancer (MCF-7) cell line (Filardo et al.